COGSTATE LIMITED

Cogstate develops innovative digital cognitive assessment tools that enable accurate, reliable brain health measurement for clinical trials, pharmaceutical research, and healthcare screening.

COGSTATE LIMITED Share Price & Chart

About COGSTATE LIMITED (ASX:CGS)

Cogstate is a pioneering neuroscience solutions company dedicated to revolutionizing brain health measurement through innovative digital technologies. With over 25 years of experience, the company combines cognitive science, operational excellence, and cutting-edge digital innovations to simplify and improve cognitive assessment in both clinical research and healthcare settings. Their mission is to provide valid, reliable, and scientifically-backed tools that offer deeper insights into cognitive health.

The company specializes in developing easy-to-use digital cognitive assessment solutions that support various needs, including clinical trials, pharmaceutical research, and healthcare screening. Their comprehensive suite of services encompasses digital cognitive assessments, endpoint data quality management, remote assessment capabilities, and healthcare cognitive screening tools. By creating highly sensitive and reliable cognitive tests, Cogstate helps researchers, pharmaceutical companies, and healthcare providers gather more accurate and meaningful data about brain health.

Cogstate’s global impact is significant, having supported thousands of academic and clinical trials across multiple indications and languages. Their approach focuses on making cognitive assessment more accessible, consistent, and informative, with the ultimate goal of improving brain health outcomes. The company works closely with pharmaceutical companies, academic institutions, and healthcare providers, offering innovative solutions that simplify the complex process of measuring and understanding cognitive function.

Get Our "Big News" Alerts
Join 20,000+ subscribers today.

Breaking ASX Alerts Direct to Your Inbox

Join +20,000 subscribers receiving alerts.

Join thousands of investors who rely on StockWire X for timely, accurate market intelligence.

About the Publisher